Neurocrine Biosciences Inc (NBIX)
136.62
-2.95
(-2.11%)
USD |
NASDAQ |
May 10, 16:00
136.62
0.00 (0.00%)
After-Hours: 20:00
Neurocrine Biosciences Price: 136.62 for May 10, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 09, 2024 | 139.36 | 140.71 | 138.95 | 139.57 | 394498.0 |
| May 08, 2024 | 143.50 | 143.54 | 138.15 | 139.02 | 653668.0 |
| May 07, 2024 | 142.03 | 143.86 | 140.90 | 143.19 | 667258.0 |
| May 06, 2024 | 140.55 | 143.57 | 140.55 | 141.71 | 495129.0 |
| May 03, 2024 | 140.90 | 141.88 | 139.23 | 140.71 | 616567.0 |
| May 02, 2024 | 143.79 | 144.09 | 139.63 | 139.83 | 882407.0 |
| May 01, 2024 | 140.18 | 145.22 | 136.01 | 143.03 | 1.602M |
| Apr 30, 2024 | 138.07 | 140.47 | 137.34 | 137.54 | 966534.0 |
| Apr 29, 2024 | 136.05 | 139.37 | 136.05 | 138.89 | 681748.0 |
| Apr 26, 2024 | 137.47 | 138.63 | 135.17 | 135.99 | 717575.0 |
| Apr 25, 2024 | 139.37 | 139.37 | 136.06 | 137.76 | 735781.0 |
| Apr 24, 2024 | 140.89 | 144.70 | 138.01 | 138.97 | 927988.0 |
| Apr 23, 2024 | 141.00 | 145.00 | 139.22 | 140.09 | 1.608M |
| Apr 22, 2024 | 132.48 | 134.18 | 131.79 | 133.66 | 575067.0 |
| Apr 19, 2024 | 132.65 | 133.65 | 130.13 | 132.00 | 556303.0 |
| Apr 18, 2024 | 133.23 | 134.20 | 131.00 | 132.54 | 586541.0 |
| Apr 17, 2024 | 133.11 | 134.44 | 131.36 | 133.23 | 571093.0 |
| Apr 16, 2024 | 131.78 | 135.18 | 131.49 | 132.99 | 1.033M |
| Apr 15, 2024 | 134.97 | 137.00 | 131.52 | 131.74 | 767245.0 |
| Apr 12, 2024 | 136.22 | 137.78 | 134.63 | 134.66 | 577344.0 |
| Apr 11, 2024 | 138.03 | 138.67 | 135.28 | 135.93 | 809142.0 |
| Apr 10, 2024 | 138.45 | 140.54 | 137.09 | 138.09 | 639131.0 |
| Apr 09, 2024 | 140.07 | 141.45 | 138.00 | 138.94 | 598996.0 |
| Apr 08, 2024 | 138.03 | 139.68 | 137.72 | 139.44 | 615701.0 |
| Apr 05, 2024 | 137.43 | 139.75 | 136.03 | 138.92 | 458610.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
72.45
Minimum
Jan 27 2022
143.74
Maximum
Mar 21 2024
103.37
Average
100.08
Median
Sep 23 2019
Price Benchmarks
| Globus Medical Inc | 64.73 |
| Inspire Medical Systems Inc | 167.82 |
| AIM ImmunoTech Inc | 0.4033 |
| Protalix BioTherapeutics Inc | 1.11 |
| Armata Pharmaceuticals Inc | 2.83 |
Price Related Metrics
| PE Ratio | 37.64 |
| PS Ratio | 7.015 |
| PEG Ratio | 0.0745 |
| Price to Book Value | 5.762 |
| Price to Free Cash Flow | 22.63 |
| Earnings Yield | 2.66% |
| Market Cap | 13.75B |
| PEGY Ratio | 0.0745 |
| Operating PE Ratio | 29.56 |
| Normalized PE Ratio | 46.30 |